<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Lab Resource: Stem Cell Line Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai virus technology</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-09-13">13 September 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Bella</forename><surname>Rossbach</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Föhrer Strasse 15</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Laura</forename><surname>Hildebrand</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Föhrer Strasse 15</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Linda</forename><surname>El-Ahmad</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Föhrer Strasse 15</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Berlin Institute of Health</orgName>
								<orgName type="institution" key="instit2">Stem Cell Core Facility</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Harald</forename><surname>Stachelscheid</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Föhrer Strasse 15</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Berlin Institute of Health</orgName>
								<orgName type="institution" key="instit2">Stem Cell Core Facility</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Reinke</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Föhrer Strasse 15</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Andreas</forename><surname>Kurtz</surname></persName>
							<email>andreas.kurtz@charite.de</email>
							<affiliation key="aff0">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Föhrer Strasse 15</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">College of Veterinary Medicine and Research Institute for Veterinary Science</orgName>
								<orgName type="institution">Seoul National University</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Republic of Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Lab Resource: Stem Cell Line Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai virus technology</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-09-13">13 September 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">86F78501B6CC323173B4C88EFA8B8F94</idno>
					<idno type="DOI">10.1016/j.scr.2015.12.018</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We have generated a human induced pluripotent stem cell (iPSC) line derived from urinary cells of a 28 year old healthy female donor.</s><s>The cells were reprogrammed using a non-integrating viral vector and have shown full differentiation potential.</s><s>Together with the iPSC line, the donor provided blood cells for the study of immunological effects of the iPSC line and its derivatives in autologous and allogeneic settings.</s><s>The line is available and registered in the human pluripotent stem cell registry as BCRTi005-A.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>growth factor (hEGF, all Peprotech) and the REGM SingleQuot kit.</s><s>First colonies appeared on day 5.</s><s>After reaching about 90% confluency, cells were passaged using trypsin (Biochrom) and replated on gelatin coated dishes in a ratio of 1:10.</s><s>Cells were frozen in FBS containing 10% dimethylsulfoxid (DMSO).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reprogramming and hiPSC maintenance</head><p><s>Urinary cells were thawed and cultivated in RPMI (Gibco) medium supplemented with 10% FBS and 1% P/S on gelatin coated dishes until reaching confluence of around 90% again.</s><s>The Sendai virus (SeV) based non-integration CytoTune™ iPS Reprogramming Kit (Life Technologies) <ref type="bibr" target="#b1">(Fusaki et al., 2009)</ref> was used according to manufacturer's instructions.</s><s>First colonies appeared after 10 days.</s><s>5 single colonies were picked and cultivated under feeder free conditions on Geltrex (Life Technologies) in TeSR-E8 medium (Stemcell Technologies) supplemented with 1% P/S.</s><s>The hiPSCs were passaged every 5-7 days in a ratio of 1:6.</s><s>At passage 14, colonies were tested for virus loss and pluripotency marker expression and one of the 5 colonies was kept in culture for further analysis.</s><s>Frozen stocks of the other colonies were kept too.</s><s>Pluripotency marker staining of hiPSCs hiPSCs were fixed (BD Cytofix) and permeabilized using Perm/Wash buffer (BD) and stained with antibodies against the pluripotency markers TRA-1-60 (Novous Biologicals), TRA-1-81 (Novus Biologicals), OCT-4 PerCP-Cy5.5 (BD) and SSEA-4 FITC (R&amp;D).</s><s>Subsequently, cell nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen).</s><s>The final analysis was performed using the High Content Screening Imaging System Operetta (Perkin Elmer).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA isolation and cDNA synthesis</head><p><s>Total RNA was extracted (Qiagen RNA Mini Kit) and transcribed into cDNA using the SuperScript® III Transcriptase Kit (Life Technologies).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Detection of SeV genome and transgenes</head><p><s>After 14 passages, hiPSC lines were tested for SeV residues.</s><s>PCR was performed using primers and instructions (Table <ref type="table" target="#tab_0">1</ref>) as recommended by the manufacturer.</s><s>As positive control RNA was used from the reprogramming leftovers.</s><s>Negative control RNA was obtained from the hiPSC line WISCi004-A (IMR90, WiCell), which was lentivirally reprogrammed from IRM90.4 fibroblasts.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Embryoid body (EB) formation and germ layer differentiation</head><p><s>To test the capacity of the reprogrammed hiPSC line to spontaneously differentiate into cells of all three germ layers, hiPSCs were harvested using accutase (Gibco) and seeded in TeSR-E8 supplemented with 10 μm Rock inhibitor (StemCell Technologies) into AggreWell plates 800 (StemCell Technologies).</s><s>EBs formed within 24 h and were further cultivated on ultra-low attachment plates (Corning) in KO-DMEM (Invitrogen) supplemented with 20% Knockout SerumReplacer (Invitrogen), 1,25 mM GlutaMax™, 1% (v/v) NEAA, 0,2% (v/v) beta-Mercaptoethanol (Gibco) and P/S (100 U/ml/100 μg/ml) for 10 days.</s><s>Medium was changed every 48 h.</s></p><p><s>EBs were harvested and isolated RNA was transcribed into cDNA.</s><s>PCR was performed to analyze the expression of germ layer specific genes (Table <ref type="table" target="#tab_1">2</ref>).</s><s>The following PCR program was used: 96 °C for Fig. <ref type="figure">4</ref>. Karyotyping of hiPSC lines.</s><s>Karyogram was determined using the KaryoLite™ BoBs™ Kit.</s><s>Female and male DNA with normal karyotypes were used as reference and chromosomal signals were compared with the tested hiPSC DNA (red: against female, blue: against male DNA).</s><s>No aneuploidies were detected for the hiPSC line BCRTi005-A.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Karyogram</head><p><s>For the detection of chromosomal aberrations, the KaryoLite™ BoBs™ Kit was used supplied by Perkin Elmer <ref type="bibr" target="#b2">(Lund et al., 2012)</ref>.</s><s>Genomic DNA was processed according to the manufacturer's instructions.</s><s>Female and male controls were used in parallel.</s><s>The fluorescent signal was detected using the Bio-Plex 200 system (BioRad) and finally analyzed using the Perkin Elmer software BoBsoft™.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fingerprinting</head><p><s>Short Tandem Repeat (STR) analysis was performed to identify the purity of these cell lines.</s><s>DNA was extracted (Qiagen) from the hiPSCs and the corresponding primary cells.</s><s>The genome was analyzed for 10 different loci out of the Combined DNA Index System (CODIS):</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Morphology of primary urinary cells, reprogrammed hiPSCs and pluripotency marker expression.</s><s>(A) Phase contrast images of primary urinary cells and (B) generated hiPSCs.</s><s>(C).</s><s>hiPSC lines were stained for the pluripotency markers TRA-1-60, TRA-1-81, SSEA-4, OCT4 and DAPI for staining of nuclei.</s><s>Scale bars: A, B and: 100 μm, C: 50 μm.</s></p></div></figDesc><graphic coords="2,58.73,53.18,469.02,171.89" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Analysis of Sendai viral transgene expression in generated hiPSC lines.</s><s>RT-PCR of reprogrammed hiPSC lines was performed for the expression of Sendai virus (SeV), SeV-SOX2, SeV-KLF4, SeV-MYC and SeV-OCT3/4.</s></p></div></figDesc><graphic coords="2,87.82,285.39,143.16,188.73" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Spontaneous in vitro differentiation of hiPSCs into cells of the three germ layers.</s><s>(A) EB formation and (B) RT-PCR for the markers NANOG, Brachyury (T), Mix Paired-like Homeobox (MIXL1), Goosecoid (GSC), SRY (Sex Determining Region Y)-Box 17 (Sox17), NeuroD, Orthodenticle homeobox 2 (OTX2) and for glyceraldehyde-3-phosphate dehydrogenase (GAPDH).</s><s>Scale bar: 100 μm.</s></p></div></figDesc><graphic coords="2,129.32,546.12,328.04,162.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="3,131.41,53.18,341.35,260.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Primer sequences for Sendai viral test.</s></p></div></figDesc><table><row><cell>Target</cell><cell></cell><cell>Primer sequence</cell></row><row><cell>SeV</cell><cell>Forward</cell><cell>AAGGTCCCGGTCAAGAAACAG</cell></row><row><cell></cell><cell>Reverse</cell><cell>CTTCTGCGTCACACCATTGC</cell></row><row><cell>SOX2</cell><cell>Forward</cell><cell>TAAGGTGGATCTTCAGGTAGC</cell></row><row><cell></cell><cell>Reverse</cell><cell>CATCTCATTGGTGAGCTCCCT</cell></row><row><cell>MYC</cell><cell>Forward</cell><cell>CTGTTCCCCTCTCTCTGAAGA</cell></row><row><cell></cell><cell>Reverse</cell><cell>GGCAGAAAAGATGTGTTCCTCC</cell></row><row><cell>OCT3/4</cell><cell>Forward</cell><cell>AACGCGGAGAAGTGGAACAAG</cell></row><row><cell></cell><cell>Reverse</cell><cell>CTGTCCGAGTCCAAATCGC</cell></row><row><cell>KLF4</cell><cell>Forward</cell><cell>GTGGACCGCACGGAATTTG</cell></row><row><cell></cell><cell>Reverse</cell><cell>GGAGATTCACACCGGAGTCA</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Primer sequences for pluripotency and germ layer specification.</s></p></div></figDesc><table><row><cell>Target</cell><cell></cell><cell>Primer sequence</cell></row><row><cell>NANOG</cell><cell>Forward</cell><cell>AAGGTCCCGGTCAAGAAACAG</cell></row><row><cell></cell><cell>Reverse</cell><cell>CTTCTGCGTCACACCATTGC</cell></row><row><cell>Brachyuri (T)</cell><cell>Forward</cell><cell>TAAGGTGGATCTTCAGGTAGC</cell></row><row><cell></cell><cell>Reverse</cell><cell>CATCTCATTGGTGAGCTCCCT</cell></row><row><cell>MIXL1</cell><cell>Forward</cell><cell>CTGTTCCCCTCTCTCTGAAGA</cell></row><row><cell></cell><cell>Reverse</cell><cell>GGCAGAAAAGATGTGTTCCTCC</cell></row><row><cell>GSC</cell><cell>Forward</cell><cell>AACGCGGAGAAGTGGAACAAG</cell></row><row><cell></cell><cell>Reverse</cell><cell>CTGTCCGAGTCCAAATCGC</cell></row><row><cell>SOX17</cell><cell>Forward</cell><cell>GTGGACCGCACGGAATTTG</cell></row><row><cell></cell><cell>Reverse</cell><cell>GGAGATTCACACCGGAGTCA</cell></row><row><cell>NEUROD1</cell><cell>Forward</cell><cell>GCCCCAGGGTTATGAGACTATCACT</cell></row><row><cell></cell><cell>Reverse</cell><cell>CCGACAGAGCCCAGATGTAGTTCTT</cell></row><row><cell>OTX2</cell><cell>Forward</cell><cell>TGTAGAAGCTATTTTTGTGGGTGA</cell></row><row><cell></cell><cell>Reverse</cell><cell>GAGCATCGTTCCATCTAACTTTTT</cell></row><row><cell>GAPDH</cell><cell>Forward</cell><cell>TTGCCATCAATGACCCCTTCA</cell></row><row><cell></cell><cell>Reverse</cell><cell>CGCCCCACTTGATTTTGGA</cell></row></table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix A. Supplementary data</head><p><s>Supplementary data to this article can be found online at http://dx.</s><s>doi.org/10.1016/j.scr.2016.09.002.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D7s820</forename><surname>D16s539</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, on RNA virus that does not interate into the host genome</title>
		<author>
			<persName><forename type="first">N</forename><surname>Fusaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nishiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Saeki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasegawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Jpn. Acad. Ser. B Phys. Biol. Sci</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="348" to="362" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">High-throughput karyotyping of human pluripotent stem cells</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Lund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nikula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rahkonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Narva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Otonkoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lahesmaa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cell Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="192" to="195" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Generation of human induced pluripotent stem cells from urine samples</title>
		<author>
			<persName><forename type="first">T</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Benda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dunzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grillari-Voglauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Esteban</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Protoc</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="2080" to="2089" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
